In the context of COPD, p38 inhibition has been observed to effectively mitigate inflammation and oxidative stress in the pulmonary and muscular tissues of affected individuals, which are closely associated with airflow restriction, respiratory distress, and reduced physical tolerance [55, 174]. This evidence concerns the gene MAPK14 and chronic obstructive pulmonary disease.